JAK1 gene polymorphisms are associated with the outcomes of hepatitis B virus infection, but not with α interferon therapy response in a Han Chinese population

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 10, 2012, Pages 1206-1210

  Chen, Kangmei ^a   Min, Hanyi ^b   Wu, Xiaopan ^a   Zhu, Xilin ^a   Li, Zhuo ^c   Li, Hui ^d   Liu, Ying ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA1B INTERFERON; JANUS KINASE 1; UNCLASSIFIED DRUG;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CHINESE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE MAP; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; VIRUS CARRIER;

ADULT; ANTIVIRAL AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; JANUS KINASE 1; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84867496591     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2012.0141     Document Type: Article

References (20)

1. Abbott W, Gane E, Winship I, et al. (2007) Polymorphism in intron 1 of the interferon-gamma gene influences both serum immunoglobulin E levels and the risk for chronic hepatitis B virus infection in Polynesians. Immunogenetics 59, 187-195.
2. Ganem D, Prince AM (2004) Hepatitis B virus infection-natural history and clinical consequences. NEnglJ Med 350, 1118-1129.
3. Jeong EG, Kim MS, Nam HK, et al. (2008) Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers. Clin Cancer Res 14, 3716-3721.
4. Kalvakolanu DV (2003) Alternate interferon signaling pathways. Pharmacol Ther 100, 1-29.
5. King JK, Yeh SH, Lin MW, et al. (2002) Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: a pilot study. Hepatology 36, 1416-1424.
6. Liu M, Cao B, Zhang H, et al. (2006) Association of interferon-gamma gene haplotype in the Chinese population with hepatitis B virus infection. Immunogenetics 58, 859-864.
7. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16, 1215.
8. Rehermann B, Nascimbeni M (2005) Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5, 215-229.
9. Saracco G, Rizzetto M (1997) A practical guide to the use of interferons in the management of hepatitis virus infections. Drugs 53, 74-85.
10. Schaefer S (2005) Hepatitis B virus: significance of genotypes. J Viral Hepat 12, 111-124.
11. Shi YY, He L (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15, 97-98.
12. Song le H, Toan NL, Xuan NT, et al (2006) A promoter polymorphism in the interferon alpha-2 gene is associated with the clinical presentation of hepatitis B. Mutat Res 601, 137-143.
13. Staerk J, Kallin A, Demoulin JB, et al. (2005) JAK1 and Tyk2 activation by the homologous polycythemia vera JAK2 V617F mutation: cross-talk with IGF1 receptor. J Biol Chem 280, 41893-41899.
14. Thio CL, Thomas DL, Carrington M (2000) Chronic viral hepatitis and the human genome. Hepatology 31, 819-827.
15. Vainchenker W, Dusa A, Constantinescu SN (2008) JAKs in pathology: role of Janus kinases in hematopoietic malignancies and immunodeficiencies. Semin Cell Dev Biol 19, 385-393.
16. Wang FS (2003) Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J Gastroenterol 9, 641-644.
17. Wilks AF, Harpur AG, Kurban RR, et al. (1991) Two novel pro-tein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase. Mol Cell Biol 11, 2057-2065.
18. Wu X, Zhu X, Zhu S, et al. (2009) A pharmacogenetic study of polymorphisms in interferon pathway genes and response to interferon-alpha treatment in chronic hepatitis B patients. Antiviral Res 83, 252-256.
19. Yamaoka K, Saharinen P, Pesu M, et al. (2004) The Janus kinases (Jaks). Genome Biol 5, 253.
20. Zhou J, Lu L, Yuen MF, et al. (2007) Polymorphisms of type I interferon receptor 1 promoter and their effects on chronic hepatitis B virus infection. J Hepatol 46, 198-205.